APEX BIOTECHNOLOGY CORP financial statements, including revenue, expenses, profit, and loss

The total revenue of 1733 for the last quarter is 410.23 M TWD, and it's 0.55% lower compared to the previous quarter. The net income of Q4 23 is 15.17 M TWD.